Related Experiment Video
Updated: May 7, 2026

Chronic Sleep Deprivation in Mouse Pups by Means of Gentle Handling
Published on: October 11, 2018
Principles of medicating children with neurodevelopmental and sleep disorders--a review
1Child Psychiatrist and Neuropsychiatrist, Department of Psychological Medicine, The Children's Hospital at Westmead, Locked Bag 4001, Westmead, Sydney, NSW, Australia 2145.
Insights
Environmental conflicts with a child's intrinsic sleep signature cause stress and behavioral issues. Addressing these conflicts requires considering both medication and social support systems for effective sleep regulation.
Area of Science:
- Child psychology
- Neurodevelopmental disorders
- Sleep medicine
Background:
- Childhood stress and behavioral difficulties often stem from a mismatch between environmental demands and intrinsic sleep patterns.
- Distorted development, particularly in the brain, can lead to altered intrinsic sleep signatures.
- The interplay between a child's sleep signature and their environment significantly impacts sleep-behavioral outcomes.
Purpose of the Study:
- To explore the impact of environmental factors on children's sleep signatures and stress-related behaviors.
- To discuss the modification of sleep-behavioral outcomes through medical and non-medical interventions.
- To outline strategies for managing treatment-resistant cases, emphasizing sleep regulation and non-medication factors.
Main Methods:
- Review of existing literature on child development, sleep, and environmental influences.
- Analysis of clinical observations regarding the efficacy of different intervention strategies.
- Discussion of factors contributing to treatment failure in vulnerable populations.
Main Results:
- Conflict between environmental demands and intrinsic sleep signatures creates stress-behavior difficulties.
- Medications can alter sleep signatures and stress responses, while non-medical interventions address environmental factors.
- For non-responders to stimulatory medication, inhibitory strategies and prioritizing sleep regulation are crucial.
Conclusions:
- Effective management of sleep-behavioral difficulties requires a dual approach, integrating medication with serious consideration of social networks.
- Re-evaluating medication priorities, shifting towards inhibitory strategies and sleep regulation, is vital for treatment-resistant children.
- Clinicians must be alert to non-medication factors that may impede treatment success in vulnerable children.
Abstract:
Conflict between the demands of the environment in which a child lives and the child's intrinsic sleep signature, produces stress-behaviour difficulties in the child. Distorted development, especially distorted brain development, often leads to distorted intrinsic sleep signatures. The sleep-behaviour outcome, arising from the conflict between each child's sleep signature and the environmental niche in which they live, can be modified by medications, on the one hand, and taking the role of kin, peer and social networks seriously. Medications alter the intrinsic sleep signature of the child and the stress response. Non-medical interventions address the demands and constraints of the child's environmental niche. When the main medication strategy to address distorted sleep involves brain stimulation, those children that do not respond will often need a reversal of medication priorities; an inhibitory strategy as a short to medium term support, sleep regulation being primary for longer term management, and stimulatory strategies used sparingly, if at all. We are often dealing with vulnerable populations, not all of which are reliable or accurate sources of information. Features of a presentation alerting the clinician to non-medication factors contributing to the failure of treatment are discussed.
More Related Videos
08:20Measuring Neural Mechanisms Underlying Sleep-Dependent Memory Consolidation During Naps in Early Childhood
Published on: October 2, 2019
06:23A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice
Published on: September 22, 2020
Related Concept Videos
Management of Insomnia
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Factors Affecting Drug Response: Overview
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Metabolism